The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAEMC.L Regulatory News (AEMC)

  • There is currently no data for AEMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Apr 2021 13:00

RNS Number : 0569W
Aberdeen Emerging Markets Inv Co Ld
20 April 2021
 

Aberdeen Emerging Markets Investment Company Limited (the "Company")

LEI: 213800RIA1NX8DP4P938

 

Result of Annual General Meeting ("AGM")

 

The Board of the Company announces that at the Company's AGM held earlier today all the resolutions were passed.

 

A summary of the resolutions and the proxy voting figures received in advance of the meeting are shown below:

 

AGM

For / Discretionary

Against

Withheld

Ordinary resolutions

Votes

%

Votes

%

1

To receive and adopt the financial statements for the year ended 31 October 2020, with the reports of the Directors and auditor thereon.

41,929,524

99.99

90

0.01

0

2

To approve the Directors' Remuneration Report (excluding the Directors' Remuneration Policy) for the year ended 31 October 2020.

41,924,410

99.99

1,961

0.01

3,242

3

To approve a dividend policy to declare four interim dividends each year and to authorise the Directors to declare such dividends.

41,928,458

99.99

1,156

0.01

0

4

To re-elect Mr Hadsley-Chaplin as a Director.

27,041,754

64.50

14,884,617

35.50

3,242

5

To re-elect Mr Collins as a Director.

28,841,324

68.79

13,085,047

31.21

3,242

6

To re-elect Mrs Green as a Director.

26,258,534

62.63

15,667,407

37.37

3,672

7

To re-elect Ms de Rochechouart as a Director.

28,840,090

68.79

13,086,054

31.21

3,469

8

To re-appoint KPMG Channel Islands Limited as auditor to the Company.

40,125,750

95.70

1,802,012

4.30

1,852

9

 

To authorise the Directors to determine the remuneration of the auditor for the forthcoming financial year.

41,929,334

99.99

280

0.01

0

10

 

To give the Company the authority to purchase its own shares.

41,928,904

99.99

710

0.01

0

11

To give the Company the authority to allot new shares.

41,928,360

99.99

1,102

0.01

152

Special Resolution

12

To waive shareholders' rights of pre-emption or similar rights which they may have under the Company's Articles of Incorporation or otherwise.

41,926,681

 

99.99

2,557

 

0.01

376

 

 

The Board has noted that shareholder proxies representing 35.50%, 31.21%. 37.37% and 31.21% of the issued capital voted against the re-election of Mr Hadsley-Chaplin, Mr Collins, Mrs Green and Ms de Rochechouart respectively. The vast majority of these shares were voted by one institution. The Board notes the reasons why the shares were voted in this way, but supports the democratic process which saw substantial support from shareholders with proxies representing 64.50%, 68.79%, 62.63% and 68.79%, respectively, voting in favour of each of those Directors.

At the time of the above meeting the Company's share capital consisted of 45,965,159 ordinary shares with voting rights and a further 8,653,348 ordinary shares held in treasury.

20 April 2021

Enquiries:

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to Aberdeen Emerging Markets Investment Company Limited)

 

William Hemmings

Tel: +44 (0)207 463 6223

 

Luke Mason

Tel +44 (0)207 463 5971

 

Vistra Fund Services (Guernsey) Limited (Company Secretary)

Tel: +44 (0)1481 726034

 

Ordinary Shares - Listing Category: Premium - Equity Closed-ended Investment Funds

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEDFFSEFSELL
Date   Source Headline
27th Oct 20213:40 pmRNSNet Asset Value(s)
26th Oct 20214:00 pmRNSResult of General Meeting
26th Oct 20211:21 pmRNSNet Asset Value(s)
25th Oct 20211:45 pmRNSNet Gearing Ratio
25th Oct 20211:40 pmRNSNet Asset Value(s)
22nd Oct 20211:45 pmRNSNet Asset Value(s)
21st Oct 20211:20 pmRNSNet Asset Value(s)
20th Oct 20213:00 pmRNSNet Asset Value(s)
19th Oct 20213:10 pmRNSNet Asset Value(s)
18th Oct 20213:05 pmRNSNet Gearing Ratio
18th Oct 20213:00 pmRNSNet Asset Value(s)
15th Oct 202111:30 amRNSNet Asset Value(s)
14th Oct 20211:31 pmRNSNet Asset Value(s)
13th Oct 20212:25 pmRNSNet Asset Value(s)
13th Oct 202111:25 amRNSPortfolio Update
12th Oct 20211:51 pmRNSNet Asset Value(s)
11th Oct 20212:35 pmRNSNet Gearing Ratio
11th Oct 20212:30 pmRNSNet Asset Value(s)
8th Oct 20211:17 pmRNSNet Asset Value(s)
7th Oct 202112:30 pmRNSNet Asset Value(s)
6th Oct 202112:30 pmRNSNet Asset Value(s)
5th Oct 20213:30 pmRNSNet Asset Value(s)
4th Oct 20213:45 pmRNSPublication of Prospectus and Circular
4th Oct 20212:50 pmRNSNet Gearing Ratio
4th Oct 20212:45 pmRNSNet Asset Value(s)
1st Oct 20212:45 pmRNSNet Asset Value(s)
30th Sep 20211:30 pmRNSNet Asset Value(s)
29th Sep 20213:00 pmRNSNet Asset Value(s)
28th Sep 20211:30 pmRNSNet Asset Value(s)
27th Sep 20211:45 pmRNSNet Gearing Ratio
27th Sep 20211:40 pmRNSNet Asset Value(s)
24th Sep 20213:30 pmRNSNet Asset Value(s)
23rd Sep 20213:30 pmRNSNet Asset Value(s)
22nd Sep 20213:30 pmRNSNet Asset Value(s)
21st Sep 20212:30 pmRNSNet Asset Value(s)
20th Sep 20212:50 pmRNSNet Gearing Ratio
20th Sep 20212:45 pmRNSNet Asset Value(s)
17th Sep 20212:00 pmRNSNet Asset Value(s)
16th Sep 20211:12 pmRNSNet Asset Value(s)
15th Sep 20211:00 pmRNSNet Asset Value(s)
15th Sep 202111:54 amRNSPortfolio Update
14th Sep 20211:48 pmRNSNet Asset Value(s)
13th Sep 20211:57 pmRNSNet Gearing Ratio
13th Sep 20211:55 pmRNSNet Asset Value(s)
10th Sep 20211:50 pmRNSNet Asset Value(s)
9th Sep 20211:00 pmRNSNet Asset Value(s)
9th Sep 202112:04 pmRNSUpdate regarding shares in public hands
8th Sep 20211:30 pmRNSNet Asset Value(s)
7th Sep 20211:40 pmRNSNet Asset Value(s)
3rd Sep 202112:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.